الإحصائيات الأساسية
| LEI | 549300RFQ78SLDFSHF49 |
| CIK | 1803737 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Enhabit, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| August 7, 2025 |
Exhibit 10.2 FORM OF ENHABIT, INC. RESTRICTED STOCK UNIT AGREEMENT Pursuant to the ENHABIT, INC. 2025 EQUITY AND INCENTIVE COMPENSATION PLAN (Directors) This Restricted Stock Unit Agreement (this “Agreement”) is made as of (the “Grant Date”), by Enhabit, Inc., a Delaware corporation (the “Corporation”), and the grantee named below (“Grantee”) pursuant to the ENHABIT, INC. 2025 EQUITY AND INCENTIVE |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to . Commission file number: 001-41406 Enhabit, Inc. (Exact |
|
| August 6, 2025 |
Exhibit 99.1 Enhabit Reports Second Quarter 2025 Financial Results Company Increases Full-Year 2025 Guidance Company to host a conference call tomorrow, August 7, 2025, at 10 a.m. EDT DALLAS, TX – August 6, 2025 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2025. “Our second quarter resu |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| August 6, 2025 |
EX-10.2 Exhibit 10.2 ENHABIT, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Special Grant) Enhabit, Inc. (the “Company”) hereby grants to the Participant the number of Restricted Stock Units (“RSUs”) set forth below under the Enhabit, Inc. 2025 Equity and Incentive Compensation Plan (the “Plan”). The RSUs are subject to all of the terms and conditions in this Notice of Grant of Restricted Stock |
|
| August 6, 2025 |
EX-10.1 Exhibit 10.1 Execution Version TRANSITION, SEPARATION AND RELEASE AGREEMENT Advanced Homecare Management, LLC d/b/a Enhabit Home Health & Hospice (the “Company”) and Barbara A. Jacobsmeyer (“Executive”) enter into this Transition, Separation and Release Agreement (this “Agreement”), which was received by Executive on the 1st day of August, 2025, signed by Executive on the 5th day of August |
|
| August 6, 2025 |
EX-99.1 Exhibit 99.1 Enhabit Home Health & Hospice Announces CEO Transition Plan Barb Jacobsmeyer to Step Down; Board Commencing Thorough Search for Successor DALLAS – August 6, 2025 — Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that Barb Jacobsmeyer, president and CEO, and a member of the board of directors, intends to step down from these roles in July |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| August 6, 2025 |
enhabitearningsxslidesx Second Quarter Earnings Call Supplemental Information August 6, 2025 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| August 6, 2025 |
Form of Cash Retention Bonus Letter Agreement EX-10.3 Exhibit 10.3 ENHABIT, INC. , 2025 PERSONAL AND CONFIDENTIAL Dear []: This letter agreement (this “Agreement”) sets forth the terms and conditions pursuant to which Enhabit, Inc. (the “Company”) is offering you a retention bonus in the amount of $[] (the “Bonus”), including the eligibility requirements you must satisfy in order to receive the Bonus. You acknowledge and agree that the Compan |
|
| June 26, 2025 |
As filed with the Securities and Exchange Commission on June 26, 2025 As filed with the Securities and Exchange Commission on June 26, 2025 Registration No. |
|
| June 26, 2025 |
Enhabit, Inc. 2025 Equity and Incentive Compensation Plan Exhibit 4.3 ENHABIT, INC. 2025 EQUITY AND INCENTIVE COMPENSATION PLAN 1.Purpose. The purpose of this Plan is to permit the grant of awards to non-employee Directors, officers and other employees of the Company and its Subsidiaries, and certain consultants to the Company and its Subsidiaries, and to provide to such persons incentives and rewards for service and/or performance. 2.Definitions. Except |
|
| June 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 26, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| June 26, 2025 |
Calculation of Filing Fee Tables S-8 Enhabit, Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.01 per share Other 3,289,042 $ 9.28 $ 30,522,309.76 0.0001531 $ 4,672.97 Total Offering Amou |
|
| June 26, 2025 |
Enhabit, Inc. 2025 Equity Incentive Plan. Exhibit 10.1 ENHABIT, INC. 2025 EQUITY AND INCENTIVE COMPENSATION PLAN 1.Purpose. The purpose of this Plan is to permit the grant of awards to non-employee Directors, officers and other employees of the Company and its Subsidiaries, and certain consultants to the Company and its Subsidiaries, and to provide to such persons incentives and rewards for service and/or performance. 2.Definitions. Excep |
|
| June 9, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 9, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporation |
|
| June 9, 2025 |
Goldman Sachs 2025 Global Healthcare Conference June 10th, 2025 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| May 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| May 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified i |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 7, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporation) |
|
| May 7, 2025 |
First Quarter Earnings Call Supplemental Information May 8, 2025 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| May 7, 2025 |
Exhibit 99.1 Enhabit Reports First Quarter 2025 Financial Results Company to host a conference call tomorrow, May 8, 2025, at 10 a.m. EDT DALLAS, TX – May 7, 2025 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025. “Enhabit’s first quarter 2025 results are a product of steadfast executio |
|
| May 2, 2025 |
PRELIMINARY COPY DATED MAY 2, 2025 – SUBJECT TO COMPLETION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabi |
|
| March 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 19, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| March 6, 2025 |
(incorporated by reference to Exhibit 21.1 Exhibit 21.1 Enhabit, Inc. Subsidiaries Name Jurisdiction A&B Home Health Solutions, LLC Delaware Abba Home Health, L.P. Texas Advanced Homecare Home Office, LLC Delaware Advanced Homecare Management, LLC Delaware AHM Action Home Health, LP Texas AHM Texas GP, LLC Delaware AHM Texas Holdings, Inc. Delaware AHM Texas LP, Inc. Delaware Apex Hospice LLC Texas Best Home Care LP Texas Camellia Home Hea |
|
| March 6, 2025 |
Enhabit, Inc. Insider Trading Policy, amended and restated, February 19, 2025 Exhibit 19.1 ENHABIT, INC. INSIDER TRADING POLICY (as amended and restated February 19, 2025) 1.Purpose and Scope. This Insider Trading Policy (this “Policy”) provides guidelines with respect to transactions in the securities of Enhabit, Inc., a Delaware corporation (including its direct and indirect subsidiaries, the “Company” or “Enhabit”). The Company has adopted this Policy to promote complian |
|
| March 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabit, Inc. (Exact name |
|
| March 5, 2025 |
Exhibit 99.1 Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance Company to host a conference call tomorrow, March 6, 2025, at 10 a.m. EST DALLAS, TX – March 5, 2025 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. “Enhabit is exiting 2024 having executed specifi |
|
| March 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 5, 2025 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware 001-41406 47-2409192 (State or Other Jurisdiction (Commission File Number) (IRS Employer of |
|
| March 5, 2025 |
Fourth Quarter Earnings Call Supplemental Information March 5, 2025 Enhabit Home Health & Hospice 2 Disclaimers Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| February 25, 2025 |
Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors Exhibit 99.1 Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors DALLAS, TX – February 25, 2025 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its board of directors will nominate Stephan Rodgers to stand for election as a director of the company at Enhabit’s 2025 annual meeting of stockholders. Chairman of the Board Jeff Bolto |
|
| February 25, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 25, 2025 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpor |
|
| February 14, 2025 |
EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of eHealth, Inc. |
|
| December 5, 2024 |
Investor Presentation December 10, 2024 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that involve known and unknown risks and relate to, among other things, future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, our future financial performance, our projected business results, or our projected capital expenditures. |
|
| December 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 5, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| December 5, 2024 |
Enhabit Announces Participation in Upcoming BofA Home Care Conference Exhibit 99.1 Enhabit Announces Participation in Upcoming BofA Home Care Conference DALLAS, TX – November 19, 2024 – Enhabit, Inc. (NYSE: EHAB), (“Enhabit”), a leading home health and hospice provider, today announced its participation in the upcoming BofA Securities 2024 Home Care Conference. Enhabit’s President and Chief Executive Officer Barb Jacobsmeyer, incoming Chief Financial Officer Ryan So |
|
| December 4, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 4, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| December 4, 2024 |
Exhibit 99.1 Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners BIRMINGHAM, ALA. & DALLAS, TX –December 4, 2024– On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by |
|
| November 14, 2024 |
SC 13G 1 knots-sc13g111424.htm SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Enhabit, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 29332G102 (CUSIP Number) December 31, 2023 (Date of Event Which |
|
| November 14, 2024 |
EX-99.A 2 ex-a.htm JOINT FILING AGREEMENT Enhabit, Inc. SC 13G CUSIP No. 29332G102 13G Page 11 of 11 EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the common stock of The Pennant Group, Inc., dated as of November 14, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall b |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specifi |
|
| November 8, 2024 |
Enhabit, Inc. Director Deferred Compensation Plan. Exhibit 10.2 ENHABIT, INC. DIRECTOR DEFERRED COMPENSATION PLAN Enhabit, Inc. hereby adopts, effective as of October 1, 2024, the Enhabit, Inc. Director Deferred Compensation Plan. The Plan provides Non-Employee Directors the opportunity to elect to receive Common Stock in lieu of Cash Compensation. The Plan also provides Non-Employee Directors the opportunity to defer payment of such Common Stock |
|
| November 7, 2024 |
Exhibit 99.1 Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation DALLAS, TX – November 7, 2024 – Enhabit, Inc. (NYSE: EHAB), (“Enhabit”), leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next c |
|
| November 7, 2024 |
Exhibit 10.3 ENHABIT, INC. RESTRICTIVE COVENANTS AGREEMENT This RESTRICTIVE COVENANTS AGREEMENT (“Agreement”) is entered into as of , 2024 (the “Effective Date”), by and between Advanced Homecare Management, LLC, on behalf of itself, and its current, past, and future parents, subsidiaries, and other corporate affiliates, and its or their successors or assigns (collectively referred to herein as “t |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 7, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 6, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| November 6, 2024 |
Exhibit 99.1 Enhabit Reports Third Quarter 2024 Financial Results Company to host a conference call tomorrow, November 7, 2024, at 10 a.m. EST DALLAS, TX – November 6, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024. “Our continued progress in our strategies during the third |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified in |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 5, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| August 6, 2024 |
Enhabit Announces CFO Transition EX-99.1 3 a202408062024pressrelease.htm EX-99.1 Exhibit 99.1 Enhabit Announces CFO Transition DALLAS, TX – August 6, 2024 – Enhabit, Inc. (NYSE: EHAB), (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles an |
|
| August 6, 2024 |
Exhibit 99.1 Enhabit Reports Second Quarter 2024 Financial Results Company to host a conference call tomorrow, August 7, 2024, at 10 a.m. EDT DALLAS, TX – August 6, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024. “The second quarter marked our third sequential quarter demonstrat |
|
| August 6, 2024 |
EX-10.1 2 separationandreleaseagreem.htm EX-10.1 Exhibit 10.1 SEPARATION AND RELEASE AGREEMENT CRISSY B. CARLISLE (“you” or “Employee”) and Advanced Homecare Management, LLC d/b/a Enhabit Home Health & Hospice (the “Company”) enter into the following Separation and Release Agreement (“Agreement”) and acknowledge and agree as follows: 1.Your employment will terminate, without cause, effective at th |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| August 6, 2024 |
Second Quarter Earnings Call Supplemental Information August 7, 2024 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| July 26, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| July 25, 2024 |
Enhabit Announces Preliminary Results of 2024 Annual Meeting of Stockholders Exhibit 99.1 Enhabit Announces Preliminary Results of 2024 Annual Meeting of Stockholders DALLAS—July 25, 2024— Enhabit, Inc. (NYSE: EHAB) (the “Company”), a leading home health and hospice provider, today announced that the preliminary vote count of its proxy solicitor indicates that its stockholders have voted to elect eight of Enhabit’s director nominees at the 2024 Annual Meeting of Stockholde |
|
| July 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 25, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| July 22, 2024 |
July 22, 2024 Fellow Stockholders, AREX Capital Management, LP (together with its affiliates, “AREX” or “we”) is the beneficial owner of approximately 4. |
|
| July 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| July 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| July 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confiden |
|
| July 15, 2024 |
Enhabit Releases Certain Preliminary Second Quarter 2024 Results Exhibit 99.1 Enhabit Releases Certain Preliminary Second Quarter 2024 Results DALLAS, July 15, 2024 – Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host |
|
| July 15, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 15, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| July 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| July 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 5, 2024 |
July 5, 2024 Fellow Stockholders, AREX Capital Management, LP and its affiliates (together, “AREX” or “we”) are collectively the beneficial owners of approximately 2. |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| July 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| July 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 27, 2024 |
Rehabilitate Enhabit Prepared by AREX Capital Management June 2024AREX Capital Disclaimer 2 The materials contained herein (the “Materials”) represent the opinions of AREX Capital Master Fund, LP and the other participants named in its proxy solicitation (collectively, “AREX” or “we”) and are based on publicly available information with respect to Enhabit Inc. |
|
| June 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 17, 2024 |
June 17, 2024 Fellow Stockholders, AREX Capital Management, LP (together with its affiliates, “AREX” or “we”) is the beneficial owner of approximately 4. |
|
| June 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| June 11, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 10, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporatio |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 11, 2024 |
Goldman Sachs Global Healthcare Conference June 11th 2024 Enhabit Home Health & Hospice 1 Disclaimers Forward looking statements Statements contained in this presentation which are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| June 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| June 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confid |
|
| June 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confide |
|
| May 23, 2024 |
PRELIMINARY COPY DATED MAY 23, 2024 – SUBJECT TO COMPLETION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confiden |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified i |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) Information Required in Proxy Statement Schedule 14a Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 8, 2024 |
Exhibit 99.3 Enhabit Concludes Review of Strategic Alternatives Continues to Execute on Operating Plan; Commences Planned Board Transition DALLAS – May 8, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today announced Enhabit’s Board of Directors (the “Board”) has concluded the Company’s strategic review process, announced in August 2023, which was overseen by |
|
| May 8, 2024 |
Exhibit 99.1 Enhabit Reports First Quarter 2024 Financial Results Company to host a conference call tomorrow, May 9, 2024, at 10 a.m. EDT DALLAS, TX – May 8, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2024. “Our momentum exiting 2023 and through the first quarter of 2024 instills |
|
| May 8, 2024 |
First Quarter Earnings Call Supplemental Information May 9, 2024 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 8, 2024 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporation) |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabi |
|
| April 2, 2024 |
April 2, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Al Pavot Terence O’Brien Re: Enhabit, Inc. Form 10-K filed March 15, 2024 File No. 001-41406 Ladies and Gentlemen: Enhabit, Inc., a company incorporated under the laws of the state of Delaware (the “Compa |
|
| March 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabit, Inc. (Exact name |
|
| March 15, 2024 |
Exhibit 2.3 SECOND AMENDMENT TO TRANSITION SERVICES AGREEMENT THIS SECOND AMENDMENT TO TRANSITION SERVICES AGREEMENT (this “Amendment”) is effective September 1, 2023 (the “Effective Date”), by and among Encompass Health Corporation, a Delaware corporation (the “Encompass Health”), and Enhabit, Inc., a Delaware corporation (“Enhabit”). RECITALS: WHEREAS, Encompass Health and Enhabit entered into t |
|
| March 15, 2024 |
Exhibit 21.1 Enhabit, Inc. Subsidiaries Name Jurisdiction A&B Home Health Solutions, LLC Delaware Abba Home Health, L.P. Texas Advanced Homecare Management, LLC Delaware AHM Action Home Health, LP Texas AHM Texas GP, LLC Delaware AHM Texas LP, Inc. Delaware Apex Hospice LLC Texas Best Home Care LP Texas Camellia Home Health of Alabama, LLC Alabama Camellia Home Health of East Tennessee, LLC Delawa |
|
| March 15, 2024 |
Enhabit, Inc. Incentive Compensation Recoupment Policy, dated December 1, 2023 Exhibit 97.1 ENHABIT, INC. INCENTIVE COMPENSATION RECOUPMENT POLICY Effective December 1, 2023 1.Purpose. a.As required pursuant to the listing standards of the New York Stock Exchange (the “Stock Exchange”), Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10D-1 under the Exchange Act, the Compensation and Human Capital Committee (the “Committee”) of t |
|
| March 6, 2024 |
Exhibit 99.1 Enhabit Reports Fourth Quarter Results and Issues Full-Year 2024 Guidance Company to host a conference call tomorrow, March 7, 2024, at 10 A.M. EST DALLAS, TX – March 6, 2024 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2023. “Persistent focus on our Company’s strategie |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 6, 2024 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware 001-41406 47-2409192 (State or Other Jurisdiction (Commission File Number) (IRS Employer of |
|
| March 6, 2024 |
Fourth Quarter Earnings Call Supplemental Information March 7, 2024 Enhabit Home Health & Hospice 2 Disclaimers Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| February 13, 2024 |
EHAB / Enhabit, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0845-enhabitinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Enhabit Inc Title of Class of Securities: Common Stock CUSIP Number: 29332G102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pur |
|
| February 12, 2024 |
EHAB / Enhabit, Inc. / Flynn James E Passive Investment SC 13G/A 1 e619244sc13ga-enhabit.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2) * Enhabit, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29332G102 (CUSIP Number) December 31, 2023 |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specifi |
|
| November 7, 2023 |
Exhibit 10.1 Execution Version SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT, dated as of November 3, 2023 (this “Amendment”), is made among ENHABIT, INC., a Delaware corporation (the “Borrower”), the Subsidiaries party hereto (the “Subsidiary Guarantors” and, together with the Borrower, the “Loan Parties”), the Lenders (as defined below) party hereto and WELLS FAR |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 3, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpora |
|
| November 7, 2023 |
Third Quarter Earnings Call Supplemental Information November 7, 2023 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| November 7, 2023 |
Exhibit 99.1 Enhabit Reports Third Quarter 2023 Financial Results Revises Full-Year Guidance Company to host a conference call tomorrow, November 8, 2023 at 10 AM EDT DALLAS, TX – November 7, 2023 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2023. “In the midst of industry disruptio |
|
| October 5, 2023 |
Exhibit 99.1 Enhabit Home Health & Hospice Announces Date of 2023 Third Quarter Earnings Call Comments on Limited Waiver and Liquidity DALLAS, TX – Oct. 4, 2023 – Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today provided updates on the timing for release of its results for the third quarter ended Sept. 30, 2023, and certain other matters. The Company is in the |
|
| October 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 4, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporat |
|
| October 2, 2023 |
Exhibit 10.1 Execution Version LIMITED WAIVER THIS LIMITED WAIVER (this “Limited Waiver”), dated as of September 29, 2023, by and between Enhabit, Inc., a Delaware corporation (the “Borrower”), Wells Fargo Bank, National Association, as Administrative Agent for the Lenders (the “Administrative Agent”), and the undersigned Lenders. RECITALS WHEREAS, pursuant to the Credit Agreement, dated as of Jun |
|
| October 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 29, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorpo |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified in |
|
| August 14, 2023 |
Exhibit 10.2 FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENT THIS FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENT (this “Amendment”) is effective June 30, 2023 (the “Effective Date”), by and among Encompass Health Corporation, a Delaware corporation (the “Encompass Health”), and Enhabit, Inc., a Delaware corporation (“Enhabit”). RECITALS: WHEREAS, Encompass Health and Enhabit entered into that c |
|
| August 9, 2023 |
enhabitearningsxslidesx Second Quarter Earnings Call Supplemental Information August 9, 2023 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| August 9, 2023 |
Exhibit 99.1 Enhabit Reports Second Quarter 2023 Financial Results Revises Full-Year Guidance Announces Intent to Launch Strategic Alternatives Process Subject to Satisfaction of Conditions in Tax Matters Agreement Company to host a conference call tomorrow, August 10, 2023 at 10 AM EDT DALLAS, TX – August 9, 2023 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 9, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction (Commission (IRS Employer of incorporati |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 28, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Number |
|
| June 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 27, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Number |
|
| June 28, 2023 |
Exhibit 10.1 Execution Version FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of June 27, 2023 (this “Amendment”), is made among ENHABIT, INC., a Delaware corporation (the “Borrower”), the Subsidiaries party hereto (the “Subsidiary Guarantors” and, together with the Borrower, the “Credit Parties”), the lenders party hereto (the “Lenders”) and WELLS FARGO BAN |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified i |
|
| May 9, 2023 |
enhabitearningsxslidesx First Quarter Earnings Call Supplemental Information May 10, 2023 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| May 9, 2023 |
Exhibit 99.1 Enhabit Reports First Quarter 2023 Financial Results and Reaffirms Full-Year Guidance Announces new national payor agreement and two new convener agreements with national reach effective May 1, 2023 Company to host a conference call tomorrow, May 10, 2023 at 10 AM EDT DALLAS, TX – May 9, 2023 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 9, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Number) |
|
| May 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15d OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabit |
|
| April 14, 2023 |
Exhibit 99.1 CORRECTION—Enhabit, Inc. DALLAS, Texas, April 14, 2023 —This press release corrects a prior version published on February 14, 2023 and is updated to revise the Company’s previously disclosed financial results for the period ended December 31, 2022. The corrected release reads: Enhabit Reports Fourth Quarter Results and Issues Full-Year 2023 Guidance Company to host a conference call t |
|
| April 14, 2023 |
Enhabit, Inc. Insider Trading Policy, dated February 22, 2023. Exhibit 19.1 ENHABIT, INC. INSIDER TRADING POLICY 1.Purpose and Scope. This Insider Trading Policy (this “Policy”) provides guidelines with respect to transactions in the securities of Enhabit, Inc., a Delaware corporation (including its direct and indirect subsidiaries, the “Company” or “Enhabit”). The Company has adopted this Policy to promote compliance with applicable laws that prohibit certai |
|
| April 14, 2023 |
Exhibit 10.5 ENHABIT, INC. NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Employees) Enhabit, Inc. (the “Company”) hereby grants to the Participant the number of Restricted Stock Units (“RSUs”) set forth below under the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the “Plan”). The RSUs are subject to all of the terms and conditions in this Notice of Grant of Restricted Stock Units (this “Gra |
|
| April 14, 2023 |
correctedenhabitearning Fourth Quarter Earnings Call Supplemental Information Initially published - February 14, 2023 / revised - April 14, 2023 Enhabit Home Health & Hospice 2 Disclaimers Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| April 14, 2023 |
Exhibit 10.6 ENHABIT, INC. NOTICE OF GRANT OF PERFORMANCE-BASED RESTRICTED STOCK UNITS Enhabit, Inc. (the “Company”) hereby grants to the Participant the target number of performance-based Restricted Stock Units (“PRSUs”) set forth below under the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the “Plan”). The PRSUs are subject to all of the terms and conditions in this Notice of Grant of |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15d OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41406 Enhabit, Inc. (Exact name o |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 14, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 |
|
| April 14, 2023 |
Exhibit 4.1 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a summary of the terms and provisions of the capital stock of Enhabit, Inc. (the “Company,” “we,” “our” and “us”), and is qualified in its entirety by reference to our amended and restated certificate of incorporation (the “Certificate of Incorporation”) and |
|
| April 14, 2023 |
Exhibit 10.7 ENHABIT, INC. NOTICE OF GRANT OF NON-QUALIFIED STOCK OPTION (Employees) Enhabit, Inc. (the “Company”) hereby grants to the Participant an Option (the “Option”) to purchase the number of shares of Stock set forth below under the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the “Plan”). The Option is subject to all of the terms and conditions in this Notice of Grant of Non-Qua |
|
| April 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 14, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 |
|
| April 3, 2023 |
NT 10-K SEC FILE NUMBER 001-41406 CUSIP NUMBER 29332G102 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| March 30, 2023 |
EX-99.1 Exhibit 99.1 Enhabit Announces Agreement with Cruiser Capital and Harbour Point Capital Board Appointments Support the Company’s Previously Announced Board Transition Plan DALLAS – March 30, 2023 – Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC (“Cruiser”) and Harbo |
|
| March 30, 2023 |
EX-10.1 Exhibit 10.1 COOPERATION AGREEMENT This COOPERATION AGREEMENT (this “Agreement”) is made and entered into as of March 30, 2023, by and among Enhabit, Inc., a Delaware corporation (the “Company”), Cruiser Capital Master Fund LP and Cruiser Capital Advisors, LLC (collectively with their Affiliates, “Cruiser”), and Harbour Point Capital Management LP (collectively with its Affiliates, “Harbou |
|
| March 30, 2023 |
DEFA14A 1 d493395ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2023 Enhabit, Inc. (Exact name of registrant as specified in its charter) Delaware 001-41406 47-2409192 (State or other jurisdiction of |
|
| February 28, 2023 |
ENHABIT, INC. EXECUTIVE CHANGE IN CONTROL BENEFITS PLAN (Amended and Restated as of February 22, 2023) Enhabit, Inc., a Delaware corporation (the “Company”), originally adopted the Enhabit, Inc. Change in Control Benefits Plan (the “Plan”) in connection with its separation from Encompass Health Corporation for the benefit of certain Participant employees of the Company and its subsidiaries. The Pl |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 22, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Nu |
|
| February 28, 2023 |
ENHABIT, INC. EXECUTIVE SEVERANCE PLAN (Amended and Restated as of February 22, 2023) Enhabit, Inc., a Delaware corporation (the “Company”), originally adopted the Enhabit, Inc. Executive Severance Plan (the “Plan”) in connection with its separation from Encompass Health Corporation, for the benefit of certain employees of the Company and its subsidiaries. The Plan was originally effective July 1, |
|
| February 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 14, 2023 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Nu |
|
| February 15, 2023 |
Exhibit 99.1 Enhabit Reports Fourth Quarter Results and Issues Full-Year 2023 Guidance Company to host a conference call tomorrow, Feb. 15, 2023 at 10 AM EST DALLAS, TX – Feb. 14, 2022 – Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2022. “Significant changes were required in 2022 to l |
|
| February 10, 2023 |
EHAB / Enhabit Inc / Flynn James E Passive Investment SC 13G/A 1 e618231sc13ga-enhabit.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1) * Enhabit, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29332G102 (CUSIP Number) December 31, 2022 |
|
| February 9, 2023 |
EHAB / Enhabit Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0821-enhabitinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Enhabit Inc. Title of Class of Securities: Common Stock CUSIP Number: 29332G102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pu |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specifi |
|
| November 14, 2022 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ENHABIT, INC. (a Delaware corporation) Amended and Restated Bylaws of Enhabit, Inc., November 9, 2022 TABLE OF CONTENTS* Page ARTICLE I OFFICES Section 1.1 Registered Office 1 Section 1.2 Change of Location 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Annual Meeting 1 Section 2.2 Special Meetings 1 Section 2.3 List of Stockholders Entitled to Vote 2 |
|
| November 14, 2022 |
Homecare Management, Inc. d/b/a Enhabit Home Health & Hosp Exhibit 10.1 SEPARATION AND RELEASE AGREEMENT CHAD KNIGHT (“You” or “Employee”) and Advanced Homecare Management, Inc. d/b/a Enhabit Home Health & Hospice (the “Company”) enter into the following Separation and Release Agreement (“Agreement”) and acknowledge and agree as follows: 1. You have elected to resign your employment with the Company, and your employment will terminate effective close of b |
|
| November 2, 2022 |
Exhibit 99.1 Enhabit Reports Third Quarter Financial Results Company to host a conference call tomorrow, Nov. 2, 2022 at 10 AM EDT DALLAS, TX ? Nov. 1, 2022 ? Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2022. ?We are making progress on our strategic initiatives,? Enhabit?s President |
|
| November 2, 2022 |
Third Quarter Earnings Call Supplemental Information November 2, 2022 Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 1, 2022 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Num |
|
| October 14, 2022 |
EHAB / Enhabit Inc / Flynn James E Passive Investment SC 13G 1 e622010sc13g-enhabit.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. ) * Enhabit, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29332G102 (CUSIP Number) October 10, 2022 (Date |
|
| September 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 28, 2022 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File N |
|
| August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-41406 Enhabit, Inc. (Exact name of registrant as specified in |
|
| August 10, 2022 |
EHAB / Enhabit Inc / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment SC 13G 1 tv0011-enhabitinc.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Enhabit Inc. Title of Class of Securities: Common Stock CUSIP Number: 29332G102 Date of Event Which Requires Filing of this Statement: July 29, 2022 Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| August 1, 2022 |
Second Quarter Earnings Call Supplemental Information August 2, 2022 Enhabit Home Health & Hospice 2 Forward Looking Statement Statements contained in this presentation which are not historical facts, such as those relating to future events, projections, financial guidance, legislative or regulatory developments, strategy or growth opportunities, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. |
|
| August 1, 2022 |
Exhibit 99.1 Investor Relations Contact Jennifer Hills 469-621-6496 [email protected] Media Contact Erin Volbeda 214.239.6520 [email protected] Enhabit Reports Second Quarter Financial Results Company to host a conference call tomorrow, Aug. 2, 2022 at 11 AM EDT DALLAS, TX ? Aug. 1, 2022 ? Enhabit Home Health & Hospice (NYSE: EHAB), a leading home health and hospice care provider, today |
|
| August 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 1, 2022 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Numbe |
|
| July 5, 2022 |
Enhabit also announces two new appointments to its board of directors Exhibit 99.2 Enhabit Home Health & Hospice Completes Spin-off from Encompass Health Enhabit also announces two new appointments to its board of directors DALLAS ? July 1, 2022 ? Enhabit Home Health & Hospice, a leading national home health and hospice provider, today announces it is now an independent, publicly traded company following the completion of its spin-off from Encompass Health Corporati |
|
| July 5, 2022 |
EX-3.1.2 7 ny20003604x14ex3-12.htm EXHIBIT 3.1.2 Exhibit 3.1.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. (a Delaware Corporation) The undersigned, Barbara A. Jacobsmeyer certifies that she is the President and Chief Executive Officer of Enhabit, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as fo |
|
| July 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 30, 2022 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Number |
|
| July 5, 2022 |
Exhibit 2.4 EMPLOYEE MATTERS AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. DATED AS OF JUNE 30, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.01. Definitions 1 Section 1.02. Interpretation 6 ARTICLE II GENERAL PRINCIPLES FOR ALLOCATION OF LIABILITIES 6 Section 2.01. General Principles 6 Section 2.02. Service Credit Recognized by Enhabit and Enhabit Benefit |
|
| July 5, 2022 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ENHABIT, INC. (a Delaware corporation) Amended and Restated Bylaws of Enhabit, Inc., July 1, 2022 TABLE OF CONTENTS* Page ARTICLE I OFFICES Section 1.1 Registered Office 1 Section 1.2 Change of Location 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Annual Meeting 1 Section 2.2 Special Meetings 1 Section 2.3 List of Stockholders Entitled to Vote 2 Sect |
|
| July 5, 2022 |
ENHABIT, INC. EXECUTIVE SEVERANCE PLAN Exhibit 10.3 ENHABIT, INC. EXECUTIVE SEVERANCE PLAN Enhabit, Inc., a Delaware corporation (the ?Company?), has adopted the Enhabit, Inc. Executive Severance Plan (the ?Plan?), to be effective as of the date on which the Company becomes a separate publicly traded company in connection with its separation from Encompass Health Corporation, for the benefit of certain employees of the Company and its |
|
| July 5, 2022 |
EX-2.3 4 ny20003604x14ex2-3.htm EXHIBIT 2.3 Exhibit 2.3 TAX MATTERS AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION and ENHABIT, INC. DATED AS OF JUNE 30, 2022 TABLE OF CONTENTS Page Section 1. Definition of Terms 2 Section 2. Allocation of Tax Liabilities 10 Section 2.01 General Rule 10 Section 2.02 Allocation of Federal Income Tax and Federal Other Tax 10 Section 2.03 Allocation of State I |
|
| July 5, 2022 |
ENHABIT, INC. CHANGE IN CONTROL BENEFITS PLAN Exhibit 10.2 ENHABIT, INC. CHANGE IN CONTROL BENEFITS PLAN Enhabit, Inc., a Delaware corporation (the ?Company?), has adopted the Enhabit, Inc. Change in Control Benefits Plan (the ?Plan?), to be as of the date on which the Company becomes a separate publicly traded company in connection with its separation from Encompass Health Corporation for the benefit of certain Participant employees of the C |
|
| July 5, 2022 |
Exhibit 2.1 SEPARATION AND DISTRIBUTION AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. Dated as of June 30, 2022 TABLE OF CONTENTS Page SCHEDULES iii EXHIBITS iii ARTICLE I DEFINITIONS 2 ARTICLE II THE SEPARATION 13 2.1 Transfer of Assets and Assumption of Liabilities 13 2.2 Enhabit Assets; Encompass Assets 16 2.3 Enhabit Liabilities; Encompass Liabilities 18 2.4 Approvals |
|
| July 5, 2022 |
CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. EX-3.1.1 6 ny20003604x14ex3-11.htm EXHIBIT 3.1.1 Exhibit 3.1.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. Enhabit, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify: 1. This Certificate of Amendment (the “Certificate of A |
|
| July 5, 2022 |
Exhibit 2.2 TRANSITION SERVICES AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. Dated as of June 30, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 ARTICLE II SERVICES, DURATION AND SERVICES MANAGERS 4 2.1 Services 4 2.2 Duration of Services 4 2.3 Additional Unspecified Services 5 2.4 Services Not Included 6 2.5 Transitional Nature of Services 6 2.6 Transition Services |
|
| July 5, 2022 |
Exhibit 10.1 ENHABIT, INC. 2022 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 PURPOSE 1.1. General. The purpose of the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the ?Plan?) is to promote the success, and enhance the value, of Enhabit, Inc. (the ?Company?) and its subsidiaries, by linking the personal interests of their employees, officers and directors to those of Company stockholders |
|
| July 1, 2022 |
As filed with the Securities and Exchange Commission on July 1, 2022 As filed with the Securities and Exchange Commission on July 1, 2022 Registration No. |
|
| July 1, 2022 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Enhabit, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Aggregate Offering Price Per Share(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of registration fee(2) Equity Common Stock, p |
|
| July 1, 2022 |
Exhibit 4.2 AMENDED AND RESTATED BYLAWS OF ENHABIT, INC. (a Delaware corporation) Amended and Restated Bylaws of Enhabit, Inc., July 1, 2022 TABLE OF CONTENTS* Page ARTICLE I OFFICES Section 1.1 Registered Office 1 Section 1.2 Change of Location 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Annual Meeting 1 Section 2.2 Special Meetings 1 Section 2.3 List of Stockholders Entitled to Vote 2 Sect |
|
| July 1, 2022 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ENHABIT, INC. (a Delaware Corporation) Exhibit 4.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. (a Delaware Corporation) The undersigned, Barbara A. Jacobsmeyer certifies that she is the President and Chief Executive Officer of Enhabit, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), does hereby certify as follows: 1. The name of the Corporation is Enhabit, I |
|
| July 1, 2022 |
ENHABIT, INC. 2022 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 Exhibit 4.3 ENHABIT, INC. 2022 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 PURPOSE 1.1. General. The purpose of the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the ?Plan?) is to promote the success, and enhance the value, of Enhabit, Inc. (the ?Company?) and its subsidiaries, by linking the personal interests of their employees, officers and directors to those of Company stockholders a |
|
| June 21, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 17, 2022 Enhabit, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 001-41406 47-2409192 (Commission File Number |
|
| June 21, 2022 |
INFORMATION STATEMENT ENHABIT, INC. TABLE OF CONTENTS Exhibit 99.1 ? June 21, 2022 Dear Encompass Health Corporation Stockholder: We previously announced plans to separate our home health and hospice business (the ?Enhabit Business?) into an independent, publicly traded company, which we expect to list on the New York Stock Exchange under the trading symbol ?EHAB? when the separation is complete. The separation will occur through a |
|
| June 16, 2022 |
Enhabit, Inc. 6688 N. Central Expressway Suite 1300 Dallas, Texas 75206 June 16, 2022 CORRESP 1 filename1.htm Enhabit, Inc. 6688 N. Central Expressway Suite 1300 Dallas, Texas 75206 June 16, 2022 VIA EDGAR Joshua Gorsky Margaret Schwartz Franklin Wyman Mary Mast Division of Corporation Finance Office of Life Sciences U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Enhabit, Inc. Registration Statement on Form 10-12B File No. 001-41406 Ladies and G |
|
| June 15, 2022 |
As filed with the Securities and Exchange Commission on June 14, 2022. File No. 001-41406 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 Enhabit, Inc. (Exact name of Registrant as specified in its charter) Delaware ? ? 47-2409192 (S |
|
| June 15, 2022 |
TABLE OF CONTENTS Exhibit 99.1 ? [???], 2022 Dear Encompass Health Corporation Stockholder: We previously announced plans to separate our home health and hospice business (the ?Enhabit Business?) into an independent, publicly traded company, which we expect to list on the New York Stock Exchange under the trading symbol ?EHAB? when the separation is complete. The separation will occur through a di |
|
| June 9, 2022 |
Exhibit 10.5 FORM OF RESTRICTIVE COVENANTS AGREEMENT This RESTRICTIVE COVENANTS AGREEMENT (“Agreement”) is entered into as of , (the “Effective Date”), by and between Advanced Homecare Management, LLC., on behalf of itself, and its current, past, and future parents, subsidiaries, and other corporate affiliates, and its or their successors or assigns (collectively the “Company”), and the undersigne |
|
| June 9, 2022 |
FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ENHABIT, INC. (a Delaware Corporation) Exhibit 3.1 FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. (a Delaware Corporation) The undersigned, Barbara A. Jacobsmeyer certifies that she is the President and Chief Executive Officer of Enhabit, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), does hereby certify as follows: 1. The name of the Corporation is En |
|
| June 9, 2022 |
EX-10.6 11 ny20003604x7ex10-6.htm EXHIBIT 10.6 Exhibit 10.6 This document is part of a prospectus covering securities that have been registered under the Securities Act of 1933, as amended. This document may be used only in connection with our offer and sale of the securities hereunder. You cannot use this document to offer or sell the securities that you acquire hereunder to anyone else. A paper |
|
| June 9, 2022 |
Youâve Exceeded the SECâs Traffic Limit U.S. Securities and Exchange Commission Youâve Exceeded the SECâs Traffic Limit Your request rate has exceeded the SECâs maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes. Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains |
|
| June 9, 2022 |
[Wachtell, Lipton, Rosen & Katz Letterhead] June 9, 2022 CORRESP 1 filename1.htm [Wachtell, Lipton, Rosen & Katz Letterhead] June 9, 2022 VIA EDGAR SUBMISSION U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attention: Joshua Gorsky Margaret Schwartz Franklin Wyman Mary Mast Re: Enhabit, Inc. Registration Statement on Form 10-12B Filed May 25, 2022 File No. 001-41406 |
|
| June 9, 2022 |
Exhibit 2.4 FORM OF EMPLOYEE MATTERS AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. DATED AS OF [?], 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.01. Definitions 1 Section 1.02. Interpretation 6 ARTICLE II GENERAL PRINCIPLES FOR ALLOCATION OF LIABILITIES 6 Section 2.01. General Principles 6 Section 2.02. Service Credit Recognized by Enhabit and Enhabit Ben |
|
| June 9, 2022 |
EX-10.4 9 ny20003604x7ex10-4.htm EXHIBIT 10.4 Exhibit 10.4 Execution Version CREDIT AGREEMENT dated as of June 1, 2022 among ENHABIT, Inc., as the Borrower, THE LENDERS PARTY HERETO, WELLS FARGO BANK, NATIONAL ASSOCIATION as Administrative Agent, and WELLS FARGO BANK, NATIONAL ASSOCIATION as Collateral Agent WELLS FARGO SECURITIES, LLC, BANK OF AMERICA, N.A., TRUIST SECURITIES, INC., CITIBANK, N.A |
|
| June 9, 2022 |
Youâve Exceeded the SECâs Traffic Limit U.S. Securities and Exchange Commission Youâve Exceeded the SECâs Traffic Limit Your request rate has exceeded the SECâs maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes. Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains |
|
| June 9, 2022 |
Youâve Exceeded the SECâs Traffic Limit U.S. Securities and Exchange Commission Youâve Exceeded the SECâs Traffic Limit Your request rate has exceeded the SECâs maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes. Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains |
|
| June 9, 2022 |
As filed with the Securities and Exchange Commission on June 9, 2022. 10-12B/A 1 ny20003604x71012ba.htm FORM 10-12B/A As filed with the Securities and Exchange Commission on June 9, 2022. File No. 001-41406 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 Enhabit, Inc. (Exact name of Registrant as speci |
|
| June 9, 2022 |
FORM OF ENHABIT, INC. 2022 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 Exhibit 10.1 FORM OF ENHABIT, INC. 2022 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 PURPOSE 1.1. General. The purpose of the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the ?Plan?) is to promote the success, and enhance the value, of Enhabit, Inc. (the ?Company?) and its subsidiaries, by linking the personal interests of their employees, officers and directors to those of Company stock |
|
| June 9, 2022 |
Exhibit 10.7 This document is part of a prospectus covering securities that have been registered under the Securities Act of 1933, as amended. This document may be used only in connection with our offer and sale of the securities hereunder. You cannot use this document to offer or sell the securities that you acquire hereunder to anyone else. A paper version of this document and the other document |
|
| June 9, 2022 |
Youâve Exceeded the SECâs Traffic Limit TABLE OF CONTENTS Exhibit 99.1 ? [?], 2022 Dear Encompass Health Corporation Stockholder: We previously announced plans to separate our home health and hospice business (the ?Enhabit Business?) into an independent, publicly traded company, which we expect to list on the New York Stock Exchange under the trading symbol ?EHAB? when the separation is complete. The separation will occur through a dist |
|
| June 9, 2022 |
Exhibit 2.1 FORM OF SEPARATION AND DISTRIBUTION AGREEMENT BY AND BETWEEN ENCOMPASS HEALTH CORPORATION AND ENHABIT, INC. Dated as of [ ], 2022 TABLE OF CONTENTS Page SCHEDULES iii EXHIBITS iii ARTICLE I DEFINITIONS 2 ARTICLE II THE SEPARATION 13 2.1 Transfer of Assets and Assumption of Liabilities 13 2.2 Enhabit Assets; Encompass Assets 16 2.3 Enhabit Liabilities; Encompass Liabilities 18 2.4 Appro |
|
| May 25, 2022 |
Youâve Exceeded the SECâs Traffic Limit Exhibit 3.1 FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENHABIT, INC. (a Delaware Corporation) The undersigned, Barbara A. Jacobsmeyer certifies that she is the President and Chief Executive Officer of Enhabit, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), does hereby certify as follows: 1. The name of the Corporation is En |
|
| May 25, 2022 |
As filed with the Securities and Exchange Commission on May 25, 2022. As filed with the Securities and Exchange Commission on May 25, 2022. File No. 001-??? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 Enhabit, Inc. (Exact name of Registrant as specified in its charter) Delaware ? ? 47-2409192 (State or other jurisdic |
|
| May 25, 2022 |
Youâve Exceeded the SECâs Traffic Limit Exhibit 3.2 FORM OF AMENDED AND RESTATED BYLAWS OF ENHABIT, INC. (a Delaware corporation) Amended and Restated Bylaws of Enhabit, Inc., , 2022 TABLE OF CONTENTS* Page ARTICLE I OFFICES Section 1.1 Registered Office 1 Section 1.2 Change of Location 1 ARTICLE II MEETINGS OF STOCKHOLDERS Section 2.1 Annual Meeting 1 Section 2.2 Special Meetings 1 Section 2.3 List of Stockholders Entitled to Vote 2 Se |
|
| May 25, 2022 |
EX-21.1 7 ny20003604x5ex21-1.htm EXHIBIT 21.1 Exhibit 21.1 SUBSIDIARIES OF ENHABIT, INC. The following entities are expected to be subsidiaries of Enhabit, Inc. upon completion of the distribution described in the information statement. Subsidiary Name Jurisdiction of Incorporation DBA A&B Home Health Solutions, LLC DE Enhabit Home Health Abba Home Health, L.P. TX Enhabit Home Health Enhabit Hospi |
|
| May 25, 2022 |
[Wachtell, Lipton, Rosen & Katz Letterhead] May 25, 2022 CORRESP 1 filename1.htm [Wachtell, Lipton, Rosen & Katz Letterhead] May 25, 2022 VIA EDGAR SUBMISSION U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attention: Joshua Gorsky Margaret Schwartz Franklin Wyman Mary Mast Re: Enhabit, Inc. Amendment No. 1 to Draft Registration Statement on Form 10 Submitted May 6, |
|
| May 25, 2022 |
Youâve Exceeded the SECâs Traffic Limit EX-10.3 6 ny20003604x5ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 FORM OF ENHABIT, INC. EXECUTIVE SEVERANCE PLAN Enhabit, Inc., a Delaware corporation (the “Company”), has adopted the Enhabit, Inc. Executive Severance Plan (the “Plan”), to be effective as of the date on which the Company becomes a separate publicly traded company in connection with its separation from Encompass Health Corporation, for th |
|
| May 25, 2022 |
Youâve Exceeded the SECâs Traffic Limit EX-10.1 4 ny20003604x5ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 FORM OF ENHABIT, INC. 2022 OMNIBUS PERFORMANCE INCENTIVE PLAN ARTICLE 1 PURPOSE 1.1. General. The purpose of the Enhabit, Inc. 2022 Omnibus Performance Incentive Plan (the “Plan”) is to promote the success, and enhance the value, of Enhabit, Inc. (the “Company”) and its subsidiaries, by linking the personal interests of their employees, of |
|
| May 25, 2022 |
Youâve Exceeded the SECâs Traffic Limit Exhibit 10.2 FORM OF ENHABIT, INC. CHANGE IN CONTROL BENEFITS PLAN Enhabit, Inc., a Delaware corporation (the ?Company?), has adopted the Enhabit, Inc. Change in Control Benefits Plan (the ?Plan?), to be as of the date on which the Company becomes a separate publicly traded company in connection with its separation from Encompass Health Corporation for the benefit of certain Participant employees |
|
| May 25, 2022 |
EX-99.1 8 ny20003604x5ex99-1.htm EXHIBIT 99.1 TABLE OF CONTENTS Exhibit 99.1 [•], 2022 Dear Encompass Health Corporation Stockholder: We previously announced plans to separate our home health and hospice business (the “Enhabit Business”) into an independent, publicly traded company, which we expect to list on the New York Stock Exchange under the trading symbol “EHAB” when the separation is comp |
|
| May 6, 2022 |
Youâve Exceeded the SECâs Traffic Limit U.S. Securities and Exchange Commission Youâve Exceeded the SECâs Traffic Limit Your request rate has exceeded the SECâs maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes. Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains |
|
| May 6, 2022 |
DRS/A 1 filename1.htm Amendment No. 1 to confidential draft submission As confidentially submitted to the Securities and Exchange Commission on May 6, 2022. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. File No. 001- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D |
|
| May 6, 2022 |
[Wachtell, Lipton, Rosen & Katz Letterhead] May 6, 2022 DRSLTR 1 filename1.htm [Wachtell, Lipton, Rosen & Katz Letterhead] May 6, 2022 VIA EDGAR SUBMISSION U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Joshua Gorsky Margaret Schwartz Franklin Wyman Mary Mast Re: Enhabit, Inc. Draft Registration Statement on Form 10 Submitted April 4, 2022 CIK No. 0001803737 Ladies and Gentleme |
|
| April 4, 2022 |
Youâve Exceeded the SECâs Traffic Limit TABLE OF CONTENTS Exhibit 99.1 ? [?], 2022 Dear Encompass Health Corporation Stockholder: We previously announced plans to separate our home health and hospice business (the ?Enhabit Business?) into an independent, publicly traded company, which we expect to list on the New York Stock Exchange under the trading symbol ?EHAB? when the separation is complete. The separation will occur through a dist |
|
| April 4, 2022 |
DRS 1 filename1.htm As confidentially submitted to the Securities and Exchange Commission on April 1, 2022. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. File No. 001- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION O |
|
| October 1, 2020 |
Table of Contents Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-248942 CALCULATION OF REGISTRATION FEE Title of each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee (1) 4.625% Senior Notes due 2031 $400,000,000 100.0% $400,000,000 $43,640 Guarantees related t |
|
| September 30, 2020 |
SUBJECT TO COMPLETION DATED SEPTEMBER 30, 2020 424B5 1 d72911d424b5.htm FORM 424(B)(5) Table of Contents Filed pursuant to Rule 424(b)(5) Registration No. 333-248942 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy the |
|
| September 21, 2020 |
EX-25.1 Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) A National Banking |
|
| September 21, 2020 |
Form S-3ASR Table of Contents As filed with the Securities and Exchange Commission on September 21, 2020 Registration No. |
|
| May 14, 2020 |
424B5 1 d875097d424b5.htm 424B5 Table of Contents Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-220519 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount to be Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee (1) 4.500% Senior Notes due 2028 $300,000,000 99.0% $297,000,0 |
|
| May 12, 2020 |
EX-25.1 Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) A National Banking |
|
| May 12, 2020 |
SUBJECT TO COMPLETION DATED MAY 12, 2020 424B5 Table of Contents Filed pursuant to Rule 424(b)(5) Registration No. 333-220519 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction |
|
| May 12, 2020 |
POSASR As filed with the Securities and Exchange Commission on May 12, 2020 Registration No. |
